|
||||||||||||||||||||||||||||||||||
[發(fā)表評(píng)論] [本類(lèi)其他產(chǎn)品] [本類(lèi)其他供應(yīng)商] [收藏] |
銷(xiāo)售商: 上海皓元生物醫(yī)藥科技有限公司 | 查看該公司所有產(chǎn)品 >> |
MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報(bào),我們不為任何個(gè)人用途提供產(chǎn)品和服務(wù)。
Blarcamesine hydrochlorideCAS No. : 195615-84-0
MCE 國(guó)際站:Blarcamesine hydrochloride
產(chǎn)品活性:Blarcamesine hydrochloride 是一個(gè) Sigma-1 受體激動(dòng)劑,其 IC50 值為 860 nM。
研究領(lǐng)域:GPCR/G Protein | Neuronal Signaling
作用靶點(diǎn):Sigma Receptor
In Vivo: The pre-administration of Blarcamesine leads to a dose-dependent attenuation of the scopolamine induced alternation deficit, significant at 1 and 3 mg/kg. The pre-treatment with Blarcamesine hydrochloride attenuates the impairments of step-through latency, dose dependently and significantly at doses higher than 0.3 mg/kg. The Blarcamesine hydrochloride treatment dose-dependently blocks the recognition memory deficit, with a significant effect measured at 1 mg/kg. One day after injections, the significant Aβ25-35-induced decrease in Akt phosphorylation is significantly attenuated by Blarcamesine hydrochloride at 0.1 and 1 mg/kg dose. Seven days after injections, Blarcamesine hydrochloride attenuates the decrease in Ser9 phosphorylation induced by the peptide at 0.3 and 1 mg/kg. The Blarcamesine hydrochloride treatment dose-dependently prevents the Aβ25-35-induced increase in Aβ1-42 content, with a significant effect at the highest dose tested.
相關(guān)產(chǎn)品:Drug Repurposing Compound Library Plus | Clinical Compound Library Plus | Bioactive Compound Library Plus | GPCR/G Protein Compound Library | Neuronal Signaling Compound Library | Clinical Compound Library | Drug Repurposing Compound Library | Neuroprotective Compound Library | Anti-Parkinson's Disease Compound Library | Neurodegenerative Disease-related Compound Library | Targeted Diversity Library | PRE-084 hydrochloride | BD-1047 dihydrobromide | Dimemorfan phosphate | Siramesine hydrochloride | Glycerol phenylbutyrate | SR-31747 | S1RA hydrochloride | Cutamesine dihydrochloride | BD1063 dhydrochloride | Blonanserin | Sigma-2 receptor antagonist 1 | Roluperidone | OPC-14523 hydrochloride | Panamesine | PD 144418 oxalate | 4-IBP | DuP 734 | PB28 dihydrochloride | Pentoxyverine | SKF 83959 hydrobromide | σ1 Receptor antagonist-1 | Ditolylguanidine | E1R | EST64454 hydrochloride | KB-5492 anhydrous | Sigma-1 receptor antagonist 1 | Sigma-1 receptor antagonist 2
熱門(mén)產(chǎn)品線(xiàn):重組蛋白 | 化合物庫(kù) | 天然產(chǎn)物 | 染料試劑 | PROTAC | 同位素標(biāo)記物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
品牌介紹:
• MCE (MedChemExpress) 擁有數(shù)百種全球獨(dú)家化合物,我們致力于為全球科研客戶(hù)提供最新最全的高品質(zhì)小分子活性化合物;
• 10,000 多種高選擇性抑制劑、激動(dòng)劑涉及各熱門(mén)信號(hào)通路及疾病領(lǐng)域;
• 設(shè)有專(zhuān)業(yè)的實(shí)驗(yàn)中心和嚴(yán)格的質(zhì)控、驗(yàn)證體系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各項(xiàng)質(zhì)檢報(bào)告,確保產(chǎn)品的高純度、高品質(zhì);
• 產(chǎn)品的生物活性多經(jīng)各國(guó)客戶(hù)實(shí)驗(yàn)驗(yàn)證;
• Nature, Cell, Science 等多種頂級(jí)期刊及制藥專(zhuān)利收錄了MCE客戶(hù)的科研成果;
• 專(zhuān)業(yè)團(tuán)隊(duì)跟蹤最新的制藥及生命科學(xué)研究進(jìn)展,為您提供全球最新的活性化合物;
• 與世界各大制藥公司及知名科研機(jī)構(gòu)建立了長(zhǎng)期的合作。